这是一篇来自已证抗体库的有关人类 perforin的综述,是根据64篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合perforin 抗体。
perforin 同义词: HPLH2; P1; PFP

BioLegend
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 图 7a-7b
BioLegend perforin抗体(BioLegend, 308118)被用于被用于流式细胞仪在人类样本上 (图 7a-7b). elife (2020) ncbi
小鼠 单克隆(dG9)
  • 免疫组化; 小鼠; 图 2a
BioLegend perforin抗体(BioLegend, dG9)被用于被用于免疫组化在小鼠样本上 (图 2a). elife (2020) ncbi
小鼠 单克隆(dG9)
  • 免疫细胞化学; 人类; 1:50; 图 4a, 7a
BioLegend perforin抗体(Biolegend, 308108)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 4a, 7a). elife (2020) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 1:50; 图 2b
  • 免疫细胞化学; 人类; 图 2a
BioLegend perforin抗体(Biolegend, dG9)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 2b) 和 被用于免疫细胞化学在人类样本上 (图 2a). Sci Signal (2020) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 6b
BioLegend perforin抗体(Biolegend, 353307)被用于被用于流式细胞仪在人类样本上 (图 6b). Cell Mol Gastroenterol Hepatol (2020) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 2a
BioLegend perforin抗体(BioLegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunol (2019) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 图 2a
BioLegend perforin抗体(Biolegend, dG9)被用于被用于流式细胞仪在人类样本上 (图 2a). Front Immunol (2019) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 s3
BioLegend perforin抗体(BioLegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 s3). Eur J Immunol (2019) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 s1d
BioLegend perforin抗体(Biolegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 s1d). Proc Natl Acad Sci U S A (2018) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 图 1j
BioLegend perforin抗体(BioLegend, dG9)被用于被用于流式细胞仪在人类样本上 (图 1j). PLoS Pathog (2018) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 6a
BioLegend perforin抗体(Biolegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 6a). J Infect Dis (2019) ncbi
小鼠 单克隆(dG9)
  • 其他; 人类; 图 1b
BioLegend perforin抗体(BioLegend, dG9)被用于被用于其他在人类样本上 (图 1b). J Cell Biol (2018) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 2a
BioLegend perforin抗体(BioLegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 2a). Sci Immunol (2018) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 4f
BioLegend perforin抗体(BioLegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 4f). Nature (2017) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 6b
BioLegend perforin抗体(BioLegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 6b). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 图 3a
BioLegend perforin抗体(Biolegend, dG9)被用于被用于流式细胞仪在人类样本上 (图 3a). Immunity (2017) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 表 s9
BioLegend perforin抗体(BioLegend, 353303)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类
BioLegend perforin抗体(Biolegend, B-D48)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 图 1e
BioLegend perforin抗体(BioLegend, dG9)被用于被用于流式细胞仪在人类样本上 (图 1e). J Immunol (2016) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 2f
BioLegend perforin抗体(Biolegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 2f). PLoS Pathog (2016) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 6a
BioLegend perforin抗体(Biolegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 6a). J Immunol (2016) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 5 ug/ml; 图 5
BioLegend perforin抗体(BioLegend, dG9)被用于被用于流式细胞仪在人类样本上浓度为5 ug/ml (图 5). Nat Commun (2016) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 图 s1
BioLegend perforin抗体(biolegend, dG9)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2016) ncbi
小鼠 单克隆(dG9)
  • 免疫细胞化学; 人类; 图 8
BioLegend perforin抗体(BioLegend, dG9)被用于被用于免疫细胞化学在人类样本上 (图 8). J Exp Med (2015) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类
BioLegend perforin抗体(BioLegend, dG9)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2016) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 1
BioLegend perforin抗体(Biolegend, B-D48)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Pathog (2015) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 2.5 mg/ml; 图 3
BioLegend perforin抗体(BioLegend, dG9)被用于被用于流式细胞仪在人类样本上浓度为2.5 mg/ml (图 3). J Surg Res (2015) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类; 图 4
BioLegend perforin抗体(Biolegend, dG9)被用于被用于流式细胞仪在人类样本上 (图 4). Eur J Immunol (2015) ncbi
小鼠 单克隆(dG9)
  • 免疫细胞化学; 人类
BioLegend perforin抗体(BioLegend, DG9)被用于被用于免疫细胞化学在人类样本上. Cancer Res (2014) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类
BioLegend perforin抗体(Biolegend, clone dG9)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(dG9)
  • 流式细胞仪; 人类
BioLegend perforin抗体(BioLegend, dG9)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2012) ncbi
赛默飞世尔
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 perforin抗体(eBioscience, delta G9)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2017) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 3d
赛默飞世尔 perforin抗体(eBiosciences, dG9)被用于被用于流式细胞仪在人类样本上 (图 3d). Oncoimmunology (2017) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 3e
赛默飞世尔 perforin抗体(Thermo Fisher Scientific, 12-9994)被用于被用于流式细胞仪在人类样本上 (图 3e). Cell Res (2017) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔 perforin抗体(eBioscience, dG9)被用于被用于流式细胞仪在人类样本上 (图 3b). JCI Insight (2017) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 1e
赛默飞世尔 perforin抗体(ebioscience, dG9)被用于被用于流式细胞仪在人类样本上 (图 1e). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔 perforin抗体(eBioscience, d69)被用于被用于流式细胞仪在人类样本上 (图 4a). J Virol (2017) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 perforin抗体(eBioscience, gammaG9)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS Pathog (2016) ncbi
小鼠 单克隆(5B10)
  • 免疫组化-石蜡切片; 人类; 表 3
赛默飞世尔 perforin抗体(Thermo Fisher Scientific, 5B10)被用于被用于免疫组化-石蜡切片在人类样本上 (表 3). J Eur Acad Dermatol Venereol (2017) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 perforin抗体(eBioscience, dG9)被用于被用于流式细胞仪在人类样本上 (图 3). Sci Rep (2016) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 perforin抗体(eBioscience, dG9)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol (2015) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 perforin抗体(eBioscience, d69)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2015) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 perforin抗体(eBioscience, d69)被用于被用于流式细胞仪在人类样本上 (图 4). J Virol (2015) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类
赛默飞世尔 perforin抗体(eBioscience, dG9)被用于被用于流式细胞仪在人类样本上. Leukemia (2015) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类
赛默飞世尔 perforin抗体(eBioscience, dG9)被用于被用于流式细胞仪在人类样本上. Cell Immunol (2014) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 人类
赛默飞世尔 perforin抗体(eBioscience, dG9)被用于被用于流式细胞仪在人类样本上. J Exp Med (2011) ncbi
小鼠 单克隆(dG9 (delta G9))
  • 流式细胞仪; 小鼠; 图 6
赛默飞世尔 perforin抗体(eBioscience, dG9)被用于被用于流式细胞仪在小鼠样本上 (图 6). J Immunol (2010) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(B-D48)
  • 免疫组化-冰冻切片; 人类; 1:100; 图 2a-j
艾博抗(上海)贸易有限公司 perforin抗体(Abcam, B-D48)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 2a-j). Ann Clin Transl Neurol (2020) ncbi
小鼠 单克隆(CE2.10)
  • 其他; 人类; 5 ug/ml; 图 1b
艾博抗(上海)贸易有限公司 perforin抗体(Abcam, CE2.10)被用于被用于其他在人类样本上浓度为5 ug/ml (图 1b). J Cell Biol (2018) ncbi
小鼠 单克隆(B-D48)
  • mass cytometry; 人类; 图 4f
艾博抗(上海)贸易有限公司 perforin抗体(Abcam, B-D48)被用于被用于mass cytometry在人类样本上 (图 4f). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(B-D48)
  • 流式细胞仪; 人类; 图 1
艾博抗(上海)贸易有限公司 perforin抗体(Abcam, B-D48)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(A-2)
  • 免疫印迹; 人类; 1:250; 图 5c
圣克鲁斯生物技术 perforin抗体(Santa Cruz, sc-373943)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 5c). J Extracell Vesicles (2017) ncbi
小鼠 单克隆(deltaG9)
  • 免疫细胞化学; 人类; 图 3d
圣克鲁斯生物技术 perforin抗体(Santa Cruz, deltaG9)被用于被用于免疫细胞化学在人类样本上 (图 3d). Cytotherapy (2017) ncbi
小鼠 单克隆(E-5)
  • 免疫组化; 人类
圣克鲁斯生物技术 perforin抗体(Santa Cruz, sc-374346)被用于被用于免疫组化在人类样本上. Clin Cancer Res (2013) ncbi
MABTECH
小鼠 单克隆(Pf-344)
  • 流式细胞仪; 人类; 图 1d
  • 流式细胞仪; 猕猴; 图 6e
MABTECH perforin抗体(Mabtech, 3465-7)被用于被用于流式细胞仪在人类样本上 (图 1d) 和 被用于流式细胞仪在猕猴样本上 (图 6e). PLoS Pathog (2016) ncbi
小鼠 单克隆(Pf-344)
  • 流式细胞仪; African green monkey; 图 1h
MABTECH perforin抗体(Mabtech, Pf-344)被用于被用于流式细胞仪在African green monkey样本上 (图 1h). J Med Primatol (2016) ncbi
碧迪BD
小鼠 单克隆(G9)
  • 流式细胞仪; 人类; 图 s9f
碧迪BD perforin抗体(BD, ??G9)被用于被用于流式细胞仪在人类样本上 (图 s9f). Nature (2016) ncbi
  • 流式细胞仪; 人类; 图 7
碧迪BD perforin抗体(BD Biosciences, 556577)被用于被用于流式细胞仪在人类样本上 (图 7). Sci Rep (2016) ncbi
小鼠 单克隆(G9)
  • 免疫细胞化学; 人类; 10 ug/ml; 图 1
碧迪BD perforin抗体(BD Pharmingen, dletaG9)被用于被用于免疫细胞化学在人类样本上浓度为10 ug/ml (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(G9)
  • 免疫细胞化学; 人类; 图 2
碧迪BD perforin抗体(BD Pharmingen, 556434)被用于被用于免疫细胞化学在人类样本上 (图 2). Traffic (2015) ncbi
小鼠 单克隆(G9)
  • 流式细胞仪; 人类; 表 s2
碧迪BD perforin抗体(BD Biosciences, DG9)被用于被用于流式细胞仪在人类样本上 (表 s2). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(G9)
  • 流式细胞仪; 人类; 图 4
碧迪BD perforin抗体(BD Biosciences, dG9)被用于被用于流式细胞仪在人类样本上 (图 4). Cancer Immunol Res (2015) ncbi
小鼠 单克隆(G9)
  • 流式细胞仪; 人类; 表 s5
碧迪BD perforin抗体(BD Bioscience, ??G9)被用于被用于流式细胞仪在人类样本上 (表 s5). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(G9)
  • 流式细胞仪; 人类
碧迪BD perforin抗体(BD Pharmigen, deltaG9)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(G9)
  • 免疫细胞化学; 人类
碧迪BD perforin抗体(BD Biosciences, deltaG9)被用于被用于免疫细胞化学在人类样本上. Proc Natl Acad Sci U S A (2014) ncbi
徕卡显微系统(上海)贸易有限公司
小鼠 单克隆(5B10)
  • 免疫组化-石蜡切片; 人类; 表 1
徕卡显微系统(上海)贸易有限公司 perforin抗体(Novocastra, 5B10)被用于被用于免疫组化-石蜡切片在人类样本上 (表 1). Histopathology (2017) ncbi
文章列表
  1. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed 出版商
  2. Chitirala P, Chang H, Martzloff P, Harenberg C, Ravichandran K, Abdulreda M, et al. Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse. elife. 2020;9: pubmed 出版商
  3. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed 出版商
  4. Zurli V, Montecchi T, Heilig R, Poschke I, Volkmar M, Wimmer G, et al. Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells. Sci Signal. 2020;13: pubmed 出版商
  5. Bracher A, Alcalá C, Ferrer J, Melzer N, Hohlfeld R, Casanova B, et al. An expanded parenchymal CD8+ T cell clone in GABAA receptor encephalitis. Ann Clin Transl Neurol. 2020;7:239-244 pubmed 出版商
  6. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed 出版商
  7. Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells. J Immunol. 2019;203:1076-1087 pubmed 出版商
  8. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed 出版商
  9. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  10. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed 出版商
  11. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed 出版商
  12. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed 出版商
  13. Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright A, Guldevall K, et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J Cell Biol. 2018;217:3267-3283 pubmed 出版商
  14. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed 出版商
  15. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed 出版商
  16. Burr M, Sparbier C, Chan Y, Williamson J, Woods K, Beavis P, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 2017;549:101-105 pubmed 出版商
  17. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed 出版商
  18. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed 出版商
  19. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed 出版商
  20. Miyata Takata T, Takata K, Kato S, Hu L, Noujima Harada M, Chuang S, et al. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours. Histopathology. 2017;71:287-295 pubmed 出版商
  21. Jong A, Wu C, Li J, Sun J, Fabbri M, Wayne A, et al. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J Extracell Vesicles. 2017;6:1294368 pubmed 出版商
  22. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed 出版商
  23. Collins A, Rothman N, Liu K, Reiner S. Eomesodermin and T-bet mark developmentally distinct human natural killer cells. JCI Insight. 2017;2:e90063 pubmed 出版商
  24. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed 出版商
  25. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  26. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  27. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  28. Oelsner S, Friede M, Zhang C, Wagner J, Badura S, Bader P, et al. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma. Cytotherapy. 2017;19:235-249 pubmed 出版商
  29. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed 出版商
  30. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  31. Miles B, Miller S, Folkvord J, Levy D, Rakasz E, Skinner P, et al. Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. PLoS Pathog. 2016;12:e1005924 pubmed 出版商
  32. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed 出版商
  33. Torrelo A, Noguera Morel L, Hernandez Martin A, Clemente D, Barja J, Buzon L, et al. Recurrent lipoatrophic panniculitis of children. J Eur Acad Dermatol Venereol. 2017;31:536-543 pubmed 出版商
  34. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed 出版商
  35. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed 出版商
  36. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed 出版商
  37. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed 出版商
  38. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  39. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed 出版商
  40. Khazen R, Müller S, Gaudenzio N, Espinosa E, Puissegur M, Valitutti S. Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse. Nat Commun. 2016;7:10823 pubmed 出版商
  41. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  42. Dieckmann N, Hackmann Y, Aricò M, Griffiths G. Munc18-2 is required for Syntaxin 11 Localization on the Plasma Membrane in Cytotoxic T-Lymphocytes. Traffic. 2015;16:1330-41 pubmed 出版商
  43. Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A. DNAM-1 controls NK cell activation via an ITT-like motif. J Exp Med. 2015;212:2165-82 pubmed 出版商
  44. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed 出版商
  45. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed 出版商
  46. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed 出版商
  47. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed 出版商
  48. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed 出版商
  49. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed 出版商
  50. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed 出版商
  51. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed 出版商
  52. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed 出版商
  53. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed 出版商
  54. Antsiferova O, Müller A, Rämer P, Chijioke O, Chatterjee B, Raykova A, et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014;10:e1004333 pubmed 出版商
  55. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed 出版商
  56. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed 出版商
  57. Mace E, Orange J. Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A. Proc Natl Acad Sci U S A. 2014;111:6708-13 pubmed 出版商
  58. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed 出版商
  59. Poonia B, Pauza C. Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. PLoS ONE. 2014;9:e88884 pubmed 出版商
  60. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  61. Frederick D, Piris A, Cogdill A, Cooper Z, Lezcano C, Ferrone C, et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013;19:1225-31 pubmed 出版商
  62. Radvanyi L, Bernatchez C, Zhang M, Fox P, Miller P, Chacon J, et al. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2012;18:6758-70 pubmed 出版商
  63. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed 出版商
  64. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed 出版商